News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kraus Carl N
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Kraus Carl N (Chief Medical Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 06/30/2023 |
3
| Kraus Carl N (CHIEF MEDICAL OFFICER) has filed a Form 3 on Aquestive Therapeutics, Inc. |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Kraus Carl N (Chief Medical Officer) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Exercised 440,844 options to buy
@ $208.76, valued at
$92M
|
|
| 09/30/2022 |
4
| Kraus Carl N (Chief Medical Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 651,364 options to buy
@ $12.28, valued at
$8M
Granted 6,843 options to buy
@ $12280, valued at
$84M
Granted 6,843 options to buy
@ $0 |
|
| 09/30/2022 |
3
| Kraus Carl N (Chief Medical Officer) has filed a Form 3 on IDERA PHARMACEUTICALS, INC. |
|
|